Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Nanoform launches “STARMAP[®] Online” placing AI-power at the fingertips of medicine developers

Press release Nanoform Finland Plc May 4[th], 2022 09:00 a.m. Finnish time / 08:00 a.m. Swedish time Nanoform launches “STARMAP[®] Online” placing AI-power at the fingertips of medicine developers Helsinki, Finland – Nanoform Finland Plc., an innovative nanoparticle medicine-enabling company, today announced that it has launched its sparse-data AI solution (STARMAP[®] Online) as a secure online portal for direct use by its current and future partners. Since its inception in 2020, STARMAP[® ]has been actively used by Nanoform to provide its clients with a confident

INTERIM REPORT FIRST QUARTER 2022

RECORD HIGH REVENUES OF €46.3 MILLION IN Q1 2022· Revenues increased by 31.7% to €46.3 million (35.2).       · EBITDA increased by 18.7 % to €8.2 million (6.9).               · The EBITDA margin amounted to 17.8% (19.7%).                · EBIT increased by 13.6% to € 5.6 million (4.9).     · Earnings after tax increased by 4.7% to €4.8 million (4.5).              · Earnings per share amounted to €0.10 (0.10) *B2C as discontinued operations in Q1 2021 and based on net royalties during Q1 2022. SIGNIFICANT EVENTS IN THE QUARTER AND AFTER THE END OF THE QUARTER · GLI-

Reminder: Invitation to presentation of Orkla’s first quarter 2022 results, Thursday 5 May

Orkla will report its first quarter 2022 results on Thursday, 5 May 2022 at 7.00 a.m. CET.The quarterly report and the presentation material will be available at this time at: https://investors.orkla.com.The quarterly results will be presented at 8.00 a.m. CET at the Orkla House, Drammensveien 149, Oslo. The presentation and subsequent Q&A session will be held in English and may be viewed in a live webcast at https://investors.orkla.com (direct link: https://events.webcast.no/orkla-asa-1/presentations/yVMiN2YavJkVNMeJy5LP) or followed by telephone (listen only): Dial-in details:

Publication of Orthex’s Q1 Interim report on 11 May 2022 and invitation to the result presentation on the same day

Orthex Corporation, Press release, 4 May 2022 at 9.00 a.m. EESTOrthex will publish its Interim report for the period of January−March 2022 on Wednesday, 11 May 2022 at around 09:00 a.m. EEST.Orthex’s CEO Alexander Rosenlew and CFO Saara Mäkelä will present the Interim report on the same day at 11:00 a.m. EEST in a webcast. The webcast can be joined through this link.  The webcast presentation will be held in English.Q&A:Questions to the management can be sent through the meeting chat.Presentation material:The

CONCENTRIC INTERIM REPORT JANUARY – MARCH 2022

FIRST QUARTER 2022 · Net sales: MSEK 934 (432) – reported sales were up +116% year-on year. After adjusting for the impact of currency (+18%) and EMP (+74%), sales on a like for like basis, in constant currency year-on-year were up +24%. · Operating income: Operating income was MSEK 166 (95) generating an Operating margin of 17.8% (21.9). The quarter includes a full three months of trading for EMP, diluting Operating margin. · Net income for the period: MSEK 130 (72); basic EPS of SEK 3.43 (1.90) and diluted EPS of SEK 3.41 (1.89). · Cash flow from operating activities: Cash

SaltX Technology Holding AB Interim report 1 2022

FINANCIAL EVENTS  First quarter  · Net sales amounted to MSEK 0.1 (0.0)  · Operating profit/loss (EBIT) totaled MSEK -12.4 (-8.1)  · Cash flow from operating activities amounted to MSEK -12.3 (-7.8)  · Earnings per share before and after dilution amounted to SEK -0.14 (-0.11)   SIGNIFICANT EVENTS  First quarter  · SaltX presented successful results for the charging reactor in Bollmora  · SaltX and Alfa Laval in collaboration to streamline energy storage – EnerStore  · SaltX's new innovation - charging reactor with several uses   After the end of the

SynAct Pharma completes clinical pharmacokinetic test of AP1189 tablet

SynAct Pharma AB (“SynAct”) today announce that the company´s pharmacokinetic study on new tablet formulations of AP1189 has been successfully completed. The data confirms the tablet formulation as superior to, the until now used, AP1189 suspension. Further clinical development of AP1189 will be conducted using the new tablet.The study was setup with three parts. In part 1 of the study, AP1189 formulated as fast release tablets, was tested in 12 healthy volunteers in cross over design with the previously used AP1189 suspension as control. The pharmacokinetic profile of the tablets was

Oncopeptides publishes Q1 report 2022

STOCKHOLM — May 4, 2022 — Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company focused on research and development of therapies for difficult-to-treat hematological diseases, today publishes the report for the first quarter 2022.“It is with growing enthusiasm and confidence in our data that we enter into 2022”, says Jakob Lindberg, CEO of Oncopeptides. “The first quarter has been characterized by regulatory interactions in Europe and the US. The outcome of these interactions will have significant implications on the future direction of the Company, and our ability to continue

Storebrand Boligkreditt AS: Interim report Q1 2022

Storebrand Boligkreditt AS is a wholly owned subsidiary of the listed company Storebrand ASA. For information about the Storebrand Group's Q1 2022 result and Balance sheet statement, please refer to the Storebrand Group Q1 2022 interim report. Storebrand Boligkreditt AS interim report for Q1 2022 is attached.This information is subject of the disclosure requirements acc. to §5-12 vphl (Norwegian Securities Trading Act)

Storebrand Livsforsikring AS: Interim report Q1 2022

Storebrand Livsforsikring AS is a wholly owned subsidiary of the listed company Storebrand ASA. For information about the Storebrand Group's Q1 2022 result and Balance sheet statement, please refer to the Storebrand Group Q1 2022 interim report. Storebrand Livsforsikring AS interim report for Q1 2022 is attached.This information is subject of the disclosure requirements acc. to §5-12 vphl (Norwegian Securities Trading Act)

Interim Report 1 for the Period January 1 - March 31, 2022

HEATPOWER 300 MARINE - REDUCED CO\2\ EMISSIONS AND SHORTER PAYBACK TIME During the quarter, Climeon's HeatPower was brought into operation on Virgin Voyage's third cruise ship, Resilient Lady, as well as two HeatPower modules in geothermal plants in Japan. The installation work in other projects continued according to plan. The development of the new product HeatPower 300, a platform that is initially optimized for the marine market, was on schedule and the product could be presented to potential customers in connection with the trade fair Seatrade Cruise Global in Miami, USA at the end

Three month report, January–March 2022

January-March 2022 compared to January-March 2021Highlights according to segment reporting: • Revenue amounted to SEK 37.8 billion (34.4); adjusted for currency effects revenue increased 3 percent. • Operating income amounted to SEK 1.9 billion (2.3); adjusted for currency effects operating income decreased 23 percent. • Earnings per share amounted to SEK 3.62 (4.59). • Operating cash flow from operations amounted to SEK -2.8 billion (3.3), according to IFRS. • Adjusted interest-bearing net receivables(+)/net debt(-) totaled SEK 15.4 billion (December 31, 2021: 17.7),

Scandi Standards AB (publ) interim report January - March 2022

Uncertain world drives further price focusJanuary – March 2022 · Net sales amounted to MSEK 2,793 (2,469) in the first quarter 2022. At constant exchange rates net sales increased by 10 percent. · Operating income (EBIT) decreased by 58 percent to MSEK 37 (88), corresponding to a margin of 1.3 (3.5) percent. · Income for the period amounted to MSEK 10 (54). Earnings per share amounted to SEK 0.10 (0.84). · Operating cash flow was MSEK 6 (109). Significant events in the quarter · The war in Ukraine contributes to increased uncertainty regarding food supply in Europe.

STOREBRAND ASA: Results for the 1st Quarter 2022

Leading the Way in Sustainable Value Creation – Strongest Solvency Ratio on Record and Stable Operating Results, despite Turbulent Financial Markets.· Group profit[1] of NOK 628m in the 1st quarter · Operating profit of NOK 678m, up 5% y/y · Total assets under management (AuM) of NOK 1,040bn, up 5% y/y, down 5% q/q · 19% growth in overall insurance portfolio premiums, 24% growth in retail insurance (y/y) · Solvency II ratio of 184% "The first quarter of 2022 has been a shaky quarter for the world and for financial markets. We witnessed reintroduced Covid-19 restrictions at

Raisio plc’s Interim Report January−March 2022

Raisio plc’s Interim Report, May 4 2022 at 8:30 am EETStrong growth amid market and global turmoil  FINANCIAL DEVELOPMENT IN BRIEF January-March 2022, continuing operations · The Group’s net sales totalled EUR 55.1 (47.5) million, which signified a growth of 15.9%. · Comparable EBIT amounted to EUR 0.1 (4.3) million. That accounted for 0.2 (9.1)% of net sales. · EBIT was EUR -4.0* (7.1**) million, accounting for -7.3 (15.0)% of net sales. · The Healthy Food Segment’s net sales totalled EUR 35.6 (32.0) million. EBIT was EUR 2.7 (4.5) million, which accounted for 7.6 (14.1)

LMK Group reports Q1 results amid weak e-commerce environment

LMK Group, the largest supplier of meal kits in the Scandinavian region and a leader in Scandinavian foodtech, today announced its financial results for the first quarter 2022. The Group operates in Sweden, Norway and Denmark under the brands Linas Matkasse, Godtlevert, Adams Matkasse and RetNemt.CEO Walker Kinman commented: “The emergence from the pandemic, a pent-up desire for traveling and visiting restaurants, and household spending affected by soaring inflation have affected e-commerce overall, and online groceries in particular, during the quarter. This development has led to a

Assemblin Q1 2022 Interim Report

A strong start to 2022First quarter (January–March) 2022 · Net sales for the quarter increased by 26.4 per cent to SEK 3,086 million (2,442), of which 11.5 percentage points were organic growth, 13.5 were acquisition-driven and 1.4 were currency-driven. · EBITA increased to SEK 158 million (96), and the EBITA margin increased to 5.1 per cent (3.9). · The adjusted EBITA increased to SEK 176 million (131), and the adjusted EBITA margin increased to 5.7 per cent (5.3). Items affecting comparability had a negative effect on profit of SEK 18 million (35). · EBIT strengthened to SEK

Invitation to Pexip Q1 2022 Results Webcast

Pexip will present its first quarter results for 2022 on Thursday, May 12, at 17:00 CEST. The report and presentation material will be made available at 16:30 CEST at investor.pexip.com and newsweb.no. The presentation will be held in English by Trond K. Johannessen (CEO), Øystein Hem (CFO) and Åsmund Fodstad (Chief Revenue Officer). Please register using this form: https://www.pexip.com/q1-2022-results-presentation-registration . Questions can be submitted to IR@pexip.com. For further information, please contact: Investors: Mirza Koristovic, Director Investor Relations IR@

Stockmann and Wolt launch collaboration – purchases from the department store delivered conveniently to the door in about half an hour

Stockmann and technology company Wolt are launching a collaboration: From 4 May customers will be able to order beauty and home products to be delivered to their door in less than one hour via the Wolt app or website. The product range will be expanded during the spring and summer. The collaboration will initially start as a pilot lasting four months at the Stockmann in the centre of Helsinki. The pilot supports Stockmann’s new customer-centric strategy and renewal: customers can choose how and where they want to shop.Stockmann and Wolt are launching a collaboration in which shopping is

Ambea’s interim report January- March 2022

Strong quarter with favourable growth.CEO comment: Despite troubling international events, demand for our services remains favourable and our employees continue to deliver high-quality care to our care receivers. During the first quarter of the year, the focus was on growth and we completed several acquisitions, opened new residential facilities and started large manage­ment contracts. Occupancy continues to increase in our nursing homes and we opened three new units in Vardaga during the quarter, two of which were dormant during the pandemic. Both Nytida and Altiden also started new

BERGENBIO ANNOUNCES LAUNCH OF BUSINESS STRATEGY FOCUSED ON NSCLC AND COVID-19

· BerGenBio to focus on two key opportunities for its lead compound bemcentinib · Strategic focus anchored in strong scientific rationale, supported by dataset from over 600 patients demonstrating bemcentinib’s biological and clinical activity matched with significant unmet medical needs Bergen, Norway, 4 May 2022 - BerGenBio ASA (OSE:BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL inhibitors for severe unmet medical needs, announces today an update on its business strategy. BerGenBio will now focus on two key indications; 1st line non-small cell

Aker ASA: First quarter results 2022 – All time high Net Asset Value of NOK 74.7 billion

The Net Asset Value (“NAV”) of Aker ASA and holding companies (“Aker”) ended at record high NOK 74.7 billion in the first quarter of 2022, a NOK 4.9 billion, or 7.1 per cent, increase from year-end 2021.The per-share NAV amounted to NOK 1,006 as per 31 March 2022, compared to NOK 939 as per 31 December 2021. The Aker share decreased 1.8 per cent, to NOK 810 in the first quarter, compared to a 5.0 per cent increase in the benchmark index (“OSEBX”). “Russia’s invasion of Ukraine and it’s ramifications are not limited to Eastern Europe but has rattled the financial market and disrupted the

Multiconsult first quarter 2022 - All-time high results

Multiconsult ASA (OSE: MULTI)Multiconsult’s first quarter 2022 EBITA came in at NOK 169.2 million, which is an all-time high result. The EBITA margin was 14.9 per cent. Net operating revenues increased 16.2 per cent y-o-y to NOK 1 138.1 million, mainly caused by M&A and higher number of working days.  The solid result is mainly driven by strong performance in the segments Region Oslo and Region Norway, improvements in Energy, an improved billing ratio and higher number of working days. The order intake was also strong in the quarter at NOK 1 467 million, reflecting Multiconsult’s solid

Interim report January-March 2022

The property business developed well with positive net letting and rising rent levels during the first quarter. Rental income, net operating income and profit from property management increased, primarily due to a larger property portfolio. The Russian invasion of Ukraine, however, has negatively affected the valuation of the holding in the Russian fashion chain MFG.January-March 2022 · Rental income increased by 22 per cent to EUR 6,226k (5,099), as a result of a larger property portfolio and higher rent levels. In a comparable portfolio, rental income was unchanged. · Net

There are no items matching the current filter
There are no more items matching the current filter
Back to top